AUGMENTIN FOR ORAL SUSPENSION 228 mg/5 ml
Product details
Registration number: SIN09831P
Classification: Prescription Only
Active ingredients:
- AMOXYCILLIN TRIHYDRATE 229.58mg/5ml EQV AMOXYCILLIN
- POTASSIUM CLAVULANATE 33.95mg/5ml EQV CLAVULANIC ACID
Strength:
- 200 mg/5 ml
- 28.5 mg/5 ml
Dosage form: POWDER, FOR SUSPENSION
Route: ORAL
Registrant: GLAXOSMITHKLINE PTE LTD
ATC code: J01CR02
HSA approval date: 19 June 1998
Manufacturer(s):
- SmithKline Beecham Limited trading as SmithKline Beecham Pharmaceuticals
- Glaxo Wellcome Production
Manufacturing country/countries: FRANCE; UNITED KINGDOM
What are the HSA registration number and classification for AUGMENTIN FOR ORAL SUSPENSION 228 mg/5 ml?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN09831P
Classification: Prescription Only
What active ingredients and strength are recorded for AUGMENTIN FOR ORAL SUSPENSION 228 mg/5 ml?
According to the HSA dataset updated 7 August 2026:
Active ingredients:
- AMOXYCILLIN TRIHYDRATE 229.58mg/5ml EQV AMOXYCILLIN
- POTASSIUM CLAVULANATE 33.95mg/5ml EQV CLAVULANIC ACID
Strength:
- 200 mg/5 ml
- 28.5 mg/5 ml
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for AUGMENTIN FOR ORAL SUSPENSION 228 mg/5 ml?
According to the HSA dataset updated 7 August 2026:
Dosage form: POWDER, FOR SUSPENSION
Route: ORAL
Who is the recorded registrant for AUGMENTIN FOR ORAL SUSPENSION 228 mg/5 ml?
According to the HSA dataset updated 7 August 2026:
Registrant: GLAXOSMITHKLINE PTE LTD
Which manufacturers and countries are listed for AUGMENTIN FOR ORAL SUSPENSION 228 mg/5 ml?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- SmithKline Beecham Limited trading as SmithKline Beecham Pharmaceuticals
- Glaxo Wellcome Production
Manufacturing country/countries: FRANCE; UNITED KINGDOM
Where can I look up AUGMENTIN FOR ORAL SUSPENSION 228 mg/5 ml in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN09831P or the exact product name AUGMENTIN FOR ORAL SUSPENSION 228 mg/5 ml. The general register link does not preselect this product.
What are the source dates for this AUGMENTIN FOR ORAL SUSPENSION 228 mg/5 ml record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this AUGMENTIN FOR ORAL SUSPENSION 228 mg/5 ml record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN09831P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)